pBABE-Puro-KRas*G12V Citations (12)

Originally described in: Rare codons regulate KRas oncogenesis.
Lampson BL, Pershing NL, Prinz JA, Lacsina JR, Marzluff WF, Nicchitta CV, MacAlpine DM, Counter CM Curr Biol. 2013 Jan 7;23(1):70-5. doi: 10.1016/j.cub.2012.11.031. Epub 2012 Dec 13. PubMed Journal

---

Articles Citing pBABE-Puro-KRas*G12V

Articles
The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux. Wiersma VR, de Bruyn M, Wei Y, van Ginkel RJ, Hirashima M, Niki T, Nishi N, Zhou J, Pouwels SD, Samplonius DF, Nijman HW, Eggleton P, Helfrich W, Bremer E. Autophagy. 2015;11(8):1373-88. doi: 10.1080/15548627.2015.1063767. PubMed
BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer. Weaver RL, Limzerwala JF, Naylor RM, Jeganathan KB, Baker DJ, van Deursen JM. Elife. 2016 Aug 16;5. pii: e16620. doi: 10.7554/eLife.16620. PubMed
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. Mulcahy Levy JM, Zahedi S, Griesinger AM, Morin A, Davies KD, Aisner DL, Kleinschmidt-DeMasters BK, Fitzwalter BE, Goodall ML, Thorburn J, Amani V, Donson AM, Birks DK, Mirsky DM, Hankinson TC, Handler MH, Green AL, Vibhakar R, Foreman NK, Thorburn A. Elife. 2017 Jan 17;6:e19671. doi: 10.7554/eLife.19671. PubMed
Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells. Bennett Saidu NE, Bretagne M, Mansuet AL, Just PA, Leroy K, Cerles O, Chouzenoux S, Nicco C, Damotte D, Alifano M, Borghese B, Goldwasser F, Batteux F, Alexandre J. Oncotarget. 2018 Jan 10;9(10):9088-9099. doi: 10.18632/oncotarget.24144. eCollection 2018 Feb 6. PubMed
HSP90 interacts with HMGCR and promotes the progression of hepatocellular carcinoma. Dong L, Xue L, Zhang C, Li H, Cai Z, Guo R. Mol Med Rep. 2019 Jan;19(1):524-532. doi: 10.3892/mmr.2018.9667. Epub 2018 Nov 19. PubMed
Role of KRAS in regulating normal human airway basal cell differentiation. Ogawa F, Walters MS, Shafquat A, O'Beirne SL, Kaner RJ, Mezey JG, Zhang H, Leopold PL, Crystal RG. Respir Res. 2019 Aug 9;20(1):181. doi: 10.1186/s12931-019-1129-4. PubMed
Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells. Kumazaki M, Shimomura I, Kiyono T, Ochiya T, Yamamoto Y. Biochem Biophys Res Commun. 2020 Apr 30;525(2):483-490. doi: 10.1016/j.bbrc.2020.02.113. Epub 2020 Feb 25. PubMed
AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer. Ye H, Liu Y, Wu K, Luo H, Cui L. Cell Commun Signal. 2020 Jul 23;18(1):115. doi: 10.1186/s12964-020-00584-z. PubMed
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma. Castellan M, Guarnieri A, Fujimura A, Zanconato F, Battilana G, Panciera T, Sladitschek HL, Contessotto P, Citron A, Grilli A, Romano O, Bicciato S, Fassan M, Porcu E, Rosato A, Cordenonsi M, Piccolo S. Nat Cancer. 2021 Feb;2(2):174-188. doi: 10.1038/s43018-020-00150-z. Epub 2020 Dec 7. PubMed
Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer. Alhayyani S, McLeod L, West AC, Balic JJ, Hodges C, Yu L, Smith JA, Prodanovic Z, Bozinovski S, Kumar B, Ruwanpura SM, Saad MI, Jenkins BJ. Oncogene. 2022 Feb;41(6):809-823. doi: 10.1038/s41388-021-02134-4. Epub 2021 Dec 3. PubMed
Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas. Xu C, Gao Q, Wu Z, Lou W, Li X, Wang M, Wang N, Li Q. Transl Oncol. 2022 Sep 14;26:101540. doi: 10.1016/j.tranon.2022.101540. PubMed
Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2. Gong Z, Xue L, Vlantis AC, van Hasselt CA, Chan JYK, Fang J, Wang R, Yang Y, Li D, Zeng X, Tong MCF, Chen GG. J Endocrinol Invest. 2023 Dec 7. doi: 10.1007/s40618-023-02248-4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.